MEDS ▼ -12.7% - DataMEDS AI, Inc. $MEDS - DataMeds AI and Tollo Health Announce Fall 2026 Cold & Flu #Back2School50% Marketing Campaign for Viral Infections Medical Food Galectovid(TM) DataMEDS AI shares fell 12.7% today following the company's announcement of a fall 2026 marketing campaign for Galectovid, a viral infections medical food developed in partnership with Tollo Health. The significant decline suggests investors may have had different expectations for the timing, scope, or commercial potential of the initiative, though the headline does not specify a particular reason for the negative market reaction. 27-AUG-2026 04:36 PM ET